ASX - Delayed Quote • AUD Cochlear Limited (COH.AX) Follow Compare 303.25 -0.64 (-0.21%) At close: January 17 at 4:10:20 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Will Weakness in Cochlear Limited's (ASX:COH) Stock Prove Temporary Given Strong Fundamentals? With its stock down 12% over the past three months, it is easy to disregard Cochlear (ASX:COH). But if you pay close... With 51% institutional ownership, Cochlear Limited (ASX:COH) is a favorite amongst the big guns Key Insights Institutions' substantial holdings in Cochlear implies that they have significant influence over the... Cochlear (ASX:COH) Will Want To Turn Around Its Return Trends Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things... Cochlear (ASX:COH) Announces New CFO and Share Buyback Program, Signaling Strategic Growth Initiatives Cochlear (ASX:COH) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product launches, juxtaposed against a 16.7% drop in Q2 net sales and inflationary pressures. In the discussion that follows, we will delve into Cochlear's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the company's... Cochlear (ASX:COH) Appoints New CFO Amid Strong Financials and Strategic Buyback Plan Cochlear (ASX:COH) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 15% revenue increase and significant R&D investments, counterbalanced by emerging market slowdowns and high integration costs. In the discussion that follows, we will delve into Cochlear's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the company's current business situation. Healthy Aging Month | Daughter helps father win back his livelihood with cochlear implant This healthy aging month, Cochlear, the global leader in implantable hearing solutions, is highlighting the Crosby family, who are a great example of what a determined loved one can do to help a family member win back their hearing and livelihood. Those who invested in Cochlear (ASX:COH) five years ago are up 48% Cochlear Limited ( ASX:COH ) shareholders might be concerned after seeing the share price drop 11% in the last quarter... Cochlear Limited's (ASX:COH) Intrinsic Value Is Potentially 19% Below Its Share Price Key Insights The projected fair value for Cochlear is AU$244 based on 2 Stage Free Cash Flow to Equity Cochlear's... Cochlear Full Year 2024 Earnings: EPS Misses Expectations Cochlear ( ASX:COH ) Full Year 2024 Results Key Financial Results Revenue: AU$2.24b (up 16% from FY 2023). Net income... Here's Why We Think Cochlear (ASX:COH) Might Deserve Your Attention Today Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks... What Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock CochLear Ltd. Unsponsored ADR (CHEOY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Cochlear concludes Oticon Medical cochlear implant acquisition Cochlear is set to integrate the acquired business over the coming months. Cochlear Limited's (ASX:COH) Stock Been Rising: Are Strong Financials Guiding The Market? Most readers would already know that Cochlear's (ASX:COH) stock increased by 1.5% over the past month. Given that the... Cochlear (ASX:COH) May Have Issues Allocating Its Capital If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for... Institutions along with retail investors who hold considerable shares inCochlear Limited (ASX:COH) come under pressure; lose 3.3% of holdings value Key Insights The considerable ownership by retail investors in Cochlear indicates that they collectively have a greater... Investing in Cochlear (ASX:COH) five years ago would have delivered you a 104% gain Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying... Cochlear Ltd's Dividend Analysis As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Cochlear Ltd's dividend performance and assess its sustainability. What Does Cochlear Ltd Do? Should You Be Adding Cochlear (ASX:COH) To Your Watchlist Today? For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to... Cochlear calls for action in Washington D.C. ahead of World Hearing Day Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd. Are Medical Stocks Lagging Masimo (MASI) This Year? Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year. Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return COH.AX S&P/ASX 200 [XJO] YTD +4.61% +1.85% 1-Year +6.59% +12.41% 3-Year +54.79% +12.04%